Mirexus Biotechnologies is now an Industrial member of Nano Ontario.
Mirexus Biotechnologies Inc. is pleased to announce that it is now an industrial member of Nano Ontario; a not-for-profit organization that embodies the interests of the academic, industry, government and financial communities and organizes outreach activities that exemplify the ways in which nanotechnology can benefit society. “We are pleased to join Nano Ontario.” says Phil Whiting, President & CEO. “Mirexus is committed to scientific excellence and becoming a member of Nano Ontario will help enable Mirexus to improve its research impact and grow new applications of...
read moreMirexus’ phytoglycogen designated as Generally Recognized As Safe (GRAS) by an external expert panel.
Mirexus Biotechnologies Inc., is pleased to announce that an expert panel has determined the use of phytoglycogen in various foods and beverages to be GRAS (Generally Recognized As Safe). The expert review panel was made up of 3 independent scientists, qualified by their relevant national and international experience and scientific training to evaluate the safety of food ingredients. Mirexus’ phytoglycogen, trademarked under the names “Susttain™” PhytoSpherix™, Adveen™ and NanoDendrix™, is a white, odorless powder that consists primarily of phytoglycogen, (phytoglycogen is the...
read moreAlison Crumblehulme Promoted to Chief Operating Officer of Mirexus Biotechnologies Inc.
Mirexus Biotechnologies Inc. is pleased to announce the promotion of Alison Crumblehulme to Chief Operating Officer (COO). In her role as COO, Alison will ensure we produce high-quality products and embed customer-friendly processes as we grow. “Alison has been a key player in the company’s growth since joining Mirexus in 2015. Our Board of Directors is confident in her leadership and appreciative of her strong contributions to Mirexus to date,” says Phil Whiting, President & CEO. “We are entering a fast growth phase, and it was time to put strong, decisive leadership in this new...
read moreMirexus Biotechnologies Inc. Ribbon Cutting Ceremony
On Friday, September 14th 2018 Mirexus Biotechnologies Inc. held a ribbon cutting ceremony for the official grand opening of its new manufacturing and research facility in Guelph. Following the purchase of the 1.75 hectare (4.3 acre) parcel of land in July 2017, Mirexus broke ground on their development in September 2017 and completed construction this past July. The ribbon cutting ceremony was celebrated in the presence of multiple special guests whose support has made it possible for Mirexus to reach this pivotal milestone. From left to right Mayor Cam Guthrie, VP Research University of...
read moreMirexus Biotechnologies Appoints Dr. Shona McDiarmid to its Board of Directors.
Mirexus is pleased to announce the appointment of Dr. Shona McDiarmid to its Board of Directors. Shona brings a unique combination of education and experience to Mirexus which will be instrumental as we continue to build our science and patent platforms for the future. Shona has extensive experience in the biotechnology and pharmaceutical industries and is currently working as a consultant advising life sciences companies on intellectual property (IP) management strategies. Previously, Shona has been responsible at the VP or Director level for the IP functions of several companies,...
read moreMirexus Biotechnologies Relocates to New Facility in Guelph
Mirexus Biotechnologies is pleased to announce that we have relocated to our new building at 574 Hanlon Creek Boulevard, Guelph, Ontario (the corner of Hanlon Creek Blvd. and Downey Rd.). The building includes expanded lab space (to develop new personal care, nutraceutical, and biomedical applications) and offices, and most importantly a first-generation factory, designed to produce 16T / year of PhytoSpherix® – Mirexus’ safe & natural nanomaterial. The proprietary process uses only water and energy to extract this natural product from Ontario sweet corn. Dr. Phil Whiting, President and...
read more
